Norflex Related Published Studies
Well-designed clinical trials related to Norflex (Orphenadrine)
Opiate sparing effect of fixed combination of diclophenac and orphenadrine after unilateral total hip arthroplasty: A double-blind, randomized, placebo-controlled, multi-centre clinical trial. [2010.11]
Opiate sparing effect of fixed combination of diclophenac and orphenadrine after unilateral total hip arthroplasty: A double-blind, randomized, placebo-controlled, multi-centre clinical trial. [2010.10.08]
Opiate sparing effect of fixed combination of diclophenac and orphenadrine after
unilateral total hip arthroplasty: A double-blind, randomized,
placebo-controlled, multi-centre clinical trial. [2010]
[Diclofenac/orphenadrine as a combined analgetic in post-operative relief of pain] [2008.09.28]
Efficacy and safety of combined piroxicam, dexamethasone, orphenadrine, and cyanocobalamin treatment in mandibular molar surgery. [2006.09]
Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: a placebo-controlled study using laser-induced somatosensory-evoked potentials from capsaicin-induced hyperalgesic human skin. [2005]
Analgesic effects of low-dose intravenous orphenadrine in the state of capsaicin hyperalgesia. A randomised, placebo-controlled, double-blind cross-over study using laser somatosensory evoked potentials obtained from capsaicin-irritated skin in healthy volunteers. [2004]
Therapeutic response of benzodiazepine, orphenadrine citrate and occlusal splint association in TMD pain. [2003.04]
Effects of placebo, orphenadrine, and rising doses of chlorpromazine, on PAT performance in chronic schizophrenia. A two year longitudinal study. [1993.06]
5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo. [1990.12]
Well-designed clinical trials possibly related to Norflex (Orphenadrine)
[Diclofenac 75mg. and 30 mg. orfenadine (Neodolpasse) versus placebo and piroxicam in postoperative analgesia after arthroscopy] [2004]
Antiemetic efficacy of granisetron in patients with gynecological malignancies. [1997.03]
Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses. [1994.12]
Effect of central muscle relaxants on single-dose pharmacokinetics of peroral paracetamol in man. [1990.01]
Other research related to Norflex (Orphenadrine)
Orphenadrine induces secondarily generalized convulsive status epilepticus in rats. [2011.04.05]
Full recovery from a potentially lethal dose of orphenadrine ingestion using conservative treatment: a case report. [2010.11]
Determination of orphenadrine plasma levels using HPLC with diode array detection and a novel solid-phase extraction procedure in psychiatric patients. [2009.10.15]
The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine. [2009.08]
Influence of orphenadrine upon the protective activity of various antiepileptics in the maximal electroshock-induced convulsions in mice. [2009.07]
Involvement of voltage-gated sodium channels blockade in the analgesic effects of orphenadrine. [2009.04]
Pharmacokinetic, metabolism and withdrawal time of orphenadrine in camels (Camelus dromedarius) after intravenous administration. [2008.12]
Torsades de pointes in congenital long QT syndrome following low-dose orphenadrine. [2006.05]
Neuronal sensitization and its behavioral correlates in a rat model of neuropathy are prevented by a cyclic analog of orphenadrine. [2003.06]
Upregulation of cytochromes P450 2B in rat liver by orphenadrine. [2003.06]
Acute intoxication with orphenadrine and clozapine. [2001.11.15]
Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo. [2001.02]
Central anticholinergic syndrome from orphenadrine in a 3 year old. [2000.04]
Orphenadrine poisoning in a child: clinical and analytical data. [1999.10]
[Results of efficacy study with diclofenac/orphenadrine infusions in patients with musculoskeletal diseases and functional disorders] [1998]
[Diclofenac/orphenadrine infusion therapy in patients with active arthrosis] [1998]
Reduction of spastic hypertonia in patients with spinal cord injury: a double-blind comparison of intravenous orphenadrine citrate and placebo. [1995.07]
Reversal of orphenadrine-induced ventricular tachycardia with physostigmine. [1991.11]
Clinical and pharmacological review of the efficacy of orphenadrine and its combination with paracetamol in painful conditions. [1991.03]
Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrine. [1989.11]
Misleading T3-test values in psychiatric patients treated with orphenadrine. [1987]
Other possibly related research studies
Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient. [2007]
Objective high-frequency tinnitus of middle-ear myoclonus. [2004.03]
[Diagnostic image (17). Acute dystonia induced by prochlorperazine] [2000.12.23]
Anthropometric and pharmacotherapeutic variables on acute emesis induced by cisplatin-containing chemotherapy. [2000.05]
[Atypical acute dystonia] [1998.12.14]
[Fatalities caused by anticholinergic antiparkinsonian drugs. Analysis of findings in a 11-year national material] [1998.01.10]
Impaired cognitive shifting in parkinsonian patients on anticholinergic therapy. [1993.04]
Recurrent neuroleptic malignant syndrome in a man with mild mental handicap. [1992.08]
Excessive use of anticholinergic drugs in a sub-sample of Italian schizophrenics. [1991.05]
Combined levodopa-anticholinergic therapy in the treatment of Parkinson's disease. Effect on levodopa bioavailability. [1991.04]
Life-threatening ventricular arrhythmia (torsades de pointes) after haloperidol overdose. [1991.01]
Acetylcholine and choline levels in rabbit fetuses exposed to anticholinergics. [1987]
Are there alternatives to the use of quinine to treat nocturnal leg cramps? [2008.02]
Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU. [2008.01]
Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism. [2009.01]
The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study. [2009.02]
Evidence-based intravenous pain treatment with analgesic infusion regimens. [2010]
Conservative interventions provide short-term relief for non-specific neck pain: a systematic review. [2010]
Muscle relaxants for pain management in rheumatoid arthritis. [2012]
Intravenous nonopioid analgesic drugs in chronic low back pain patients on
chronic opioid treatment: a crossover, randomised, double-blinded,
placebo-controlled study. [2014]
|